Hydrogel-based vascular lineage cell growth media and uses thereof

US9447381B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9447381-B2
Application numberUS-201414553442-A
CountryUS
Kind codeB2
Filing dateNov 25, 2014
Priority dateNov 10, 2009
Publication dateSep 20, 2016
Grant dateSep 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medium for growing vascular lineage cells is described. The vascular lineage cell growth medium includes an oligosaccharide-based hydrogel and a growth factor that promotes vascularization by vascular lineage cells.

First claim

Opening claim text (preview).

We claim: 1. A method of preparing a vascular lineage cell growth medium comprising chemically bonding an adhesion promoter to an oligosaccharide, combining the chemically bonded adhesion promoter and oligosaccharide with at least one growth factor, adding a crosslinking peptide moiety, curing the combination to form a hydrogel, wherein the hydrogel has a Young's modulus between about 10 Pa and about 500 Pa; and wherein the growth factor is an amount sufficient to promote vasculogenesis and tube formation, and sufficient to stimulate MMP production in vascular lineage cells. 2. The method of claim 1 , wherein the oligosaccharide is hyaluronic acid that is from about 20% to about 90% acrylate modified and is present in an amount of about 1 wt % to about 4 wt %. 3. The method of claim 1 , wherein the adhesion promoter is present at a concentration of from about 0.1 mM to about 20 mM. 4. The method of claim 1 , wherein the crosslinking peptide moiety is present at a concentration of from about 1 mM to about 8 mM. 5. The method of claim 1 , wherein the growth factor is present at a concentration of from about 25 ng/ml to about 200 ng/ml. 6. The method of claim 1 , wherein the hydrogel allows formation of capillary-like structures (CLSs) with extended vacuoles and open lumens from vascular lineage cells. 7. The method of claim 1 , wherein the hydrogel and crosslinking peptide moiety are cleavable by an enzyme. 8. The method of claim 7 , wherein the enzyme is a matrix metalloproteinase. 9. The method of claim 8 , wherein the matrix metalloproteinase is at least one of MMP-1, MMP-2 or MMP-10. 10. The method of claim 1 , wherein the crosslinking moiety peptide comprises the sequence SEQ ID NO: 1. 11. The method of claim 1 , wherein the adhesion promoter promotes vascular lineage cell adhesion to the hydrogel and promotes vacuole and lumen formation in vascular lineage cells. 12. The method of claim 1 , wherein the hydrogel has a Young's modulus between about 10 Pa and about 250 Pa. 13. The method of claim 1 , wherein the oligosaccharide is modified with an acryl group. 14. The method of claim 1 , wherein the oligosaccharide is acrylated hyaluronic acid. 15. The method of claim 1 , wherein the growth factor is selected from the group consisting of VEGF, TNFα, SDF1-α, bFGF, angiopoetin-1, PDGF, TGF-β, PIGF or combinations thereof. 16. The method of claim 1 , wherein the adhesion promoter is a peptide that includes an RGD sequence and a reactive functional group that is capable of bonding the adhesion promoter to the oligosaccharide. 17. A vascular lineage cell growth medium prepared by the method of claim 16 , wherein the oligosaccharide is acrylated hyaluronic acid. 18. A method of inducing vascular cell morphogenesis in vivo comprising contacting a subject with a vascular construct comprising the medium of claim 17 and vascular lineage cells. 19. The method of claim 18 , wherein the crosslinking moiety peptide comprises the sequence SEQ ID NO: 1. 20. The method of claim 18 , wherein the growth factor is selected from the group consisting of VEGF, TNFα, SDF1-α, bFGF, angiopoetin-1, PDGF, TGF-β, PIGF or combinations thereof. 21. The method of claim 1 , wherein the oligosaccharide is modified with a thiol group.

Assignees

Inventors

Classifications

  • Transforming growth factor alpha [TGF-a] · CPC title

  • Vascular endothelial growth factor [VEGF] · CPC title

  • Proteins · CPC title

  • Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells · CPC title

  • Growth factors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9447381B2 cover?
A medium for growing vascular lineage cells is described. The vascular lineage cell growth medium includes an oligosaccharide-based hydrogel and a growth factor that promotes vascularization by vascular lineage cells.
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification A61L27/52. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).